Tracheotomy Timing and Outcomes in the Critically Ill: Complexity and Opportunities for Progress.

Tracheotomy Timing and Outcomes in the Critically Ill: Complexity and Opportunities for Progress.:

Related Articles

Tracheotomy Timing and Outcomes in the Critically Ill: Complexity and Opportunities for Progress.

Laryngoscope. 2020 Apr 11;:

Authors: Altman KW, Ha TN, Dorai VK, Mankidy BJ, Zhu H

Abstract

OBJECTIVES/HYPOTHESIS: To characterize the effects of tracheotomy timing at our institution on intensive care unit (ICU) length of stay (LOS) and overall hospital LOS.

STUDY DESIGN: Retrospective cohort study.

METHODS: A retrospective study was performed at a tertiary care medical center for patients undergoing tracheotomy over 2.5 years from January 1, 2016 through June 30, 2018. Demographics, survival, duration of endotracheal intubation, timing of tracheotomy, and ICU and overall hospital LOS were assessed. Tracheotomy was considered early (ET) if it was performed by day 7 of mechanical ventilation and late (LT) thereafter. Readmission, mortality, and costs were also tabulated for each aggregate group. Nonparametric statistics were used to compare results.

RESULTS: Of the 536 patients included in the analysis, 160 received tracheotomy early and 376 late. Differences between age and sex were not statistically significant. Duration of total ICU stay was shortened by 65% (12.84 ± 17.69 days vs. 38.49 ± 26.61 days; P < .0001), and length of overall hospital course was reduced by 54% (22.71 ± 26.65 days vs. 50.37 ± 34.20 days; P < .0001) in the early tracheotomy group. Observed/expected (O/E) values standardized results to case mix index and revealed LOS of 1.5 for ET and 2.5 for LT, and mortality of 0.76 for ET and 1.25 for LT, and comparable readmissions of both groups.

CONCLUSIONS: Early tracheotomy in ICU patients is associated with earlier ICU discharge, decreased length of overall hospital stay, and lower mortality when controlling for case mix index. Opportunities exist to optimize patient outcomes and O/E performance.

LEVEL OF EVIDENCE: 4 Laryngoscope, 2020.

PMID: 32277707 [PubMed - as supplied by publisher]